Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.500
-0.030 (-0.66%)
At close: Feb 17, 2026, 4:00 PM EST
4.500
0.00 (0.00%)
After-hours: Feb 17, 2026, 5:56 PM EST
Altimmune Market Cap
Altimmune has a market cap or net worth of $563.54 million as of February 17, 2026. Its market cap has increased by 13.18% in one year.
Market Cap
563.54M
Enterprise Value
368.67M
1-Year Change
13.18%
Ranking
Category
Stock Price
$4.50
Market Cap Chart
Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $563.54M, an increase of 591.46%. That is a compound annual growth rate of 9.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 472.30M | 25.48% |
| Dec 31, 2025 | 376.40M | -26.60% |
| Dec 31, 2024 | 512.80M | -15.16% |
| Dec 29, 2023 | 604.40M | -25.26% |
| Dec 30, 2022 | 808.70M | 122.17% |
| Dec 31, 2021 | 364.00M | -2.41% |
| Dec 31, 2020 | 373.00M | 1,186.21% |
| Dec 31, 2019 | 29.00M | 61.11% |
| Dec 31, 2018 | 18.00M | -42.12% |
| Dec 29, 2017 | 31.10M | -85.66% |
| Dec 30, 2016 | 216.90M | 77.06% |
| Dec 31, 2015 | 122.50M | 6.80% |
| Dec 31, 2014 | 114.70M | 17.88% |
| Dec 31, 2013 | 97.30M | 79.52% |
| Dec 31, 2012 | 54.20M | -11.58% |
| Dec 30, 2011 | 61.30M | -64.57% |
| Dec 31, 2010 | 173.00M | 210.59% |
| Dec 31, 2009 | 55.70M | -6.39% |
| Dec 31, 2008 | 59.50M | -31.77% |
| Dec 31, 2007 | 87.20M | 1.04% |
| Dec 29, 2006 | 86.30M | 4.10% |
| Dec 30, 2005 | 82.90M | 1.72% |
| Oct 6, 2005 | 81.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 599.66M |
| ProKidney | 595.65M |
| LB Pharmaceuticals | 590.48M |
| Prime Medicine | 584.23M |
| CorMedix | 578.31M |
| Design Therapeutics | 573.63M |
| Forte Biosciences | 572.57M |
| Lexicon Pharmaceuticals | 559.48M |